Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
42.22
-0.54 (-1.26%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $3.32 billion as of March 24, 2026. Its market cap has increased by 194.99% in one year.
Market Cap
3.32B
Enterprise Value
2.56B
1-Year Change
194.99%
Ranking
Category
Stock Price
$42.22
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $3.32B, an increase of 2,868.64%. That is a compound annual growth rate of 40.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 3.32B | 30.45% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.72B |
| Crinetics Pharmaceuticals | 3.60B |
| Corcept Therapeutics | 3.60B |
| ACADIA Pharmaceuticals | 3.57B |
| Dianthus Therapeutics | 3.49B |
| NewAmsterdam Pharma Company | 3.46B |
| Structure Therapeutics | 3.33B |
| Denali Therapeutics | 3.33B |